T-cell leukemia homeobox protein 2 (TLX2)

T-cell leukemia homeobox protein 2 (TLX2) is a **homeobox transcription factor** belonging to the HOX11 family, encoded by the TLX2 gene on chromosome 2. TLX2 plays a crucial regulatory role in **neural crest development** and **cell cycle control**, and is essential for the proper formation and programmed cell death of enteric neurons in the gastrointestinal tract. In human pathology, genetic or expression alterations of TLX2 are implicated in a variety of cancers, often correlating with poor prognosis, higher tumor stage, and altered immune infiltration. TLX2 is increasingly recognized as a **potential therapeutic target** and **biomarker** in oncology, with roles in chemosensitivity as well as immune microenvironment modulation. It binds DNA through its homeobox domain, typically at the consensus sequence 5'-CGGTAATTGG-3', to activate or repress transcription of downstream genes. Common aliases include HOX11L1, NCX, and Enx, reflecting its multifaceted roles in gene regulation and development. No direct small molecule modulators are known, but its involvement in resistance mechanisms and immunotherapy responsiveness makes it a topic of ongoing therapeutic interest.

Other names

HOX11L1NCXEnxHomeobox protein Hox-11L1Neural crest homeobox proteinhomeo box 11-like 1

Drug resistance mechanisms (high TLX2 expression associated with chemoresistance) Potential indirect targeting through regulation of ceRNA networks or modulation of immune response (e.g., immune checkpoint inhibition)